Transformation of human keratinocytes by SV40 virus alters their response to the tumor promoter TPA.
Recently, we have shown that transformation of human keratinocytes by SV40 virus induces the re-expression of characters found in fetal epidermis and monostratified epithelia. In the present study, TPA was found to alter some features of the human keratinocyte phenotype in a similar manner to SV40 transformation. Indeed, 12-O-tetradecanoyl-13-phorbol acetate (TPA) treatment induced the expression of cytokeratin no. 8, recognized by the monoclonal antibody TROMA-1, which is present in fetal epidermis and/or monostratified epithelia only, and fibronectin expression. However, TPA and SV40 transformation had specific non-overlapping effects. For example, TPA did not prevent terminal differentiation and stratification, as SV40-transformation did, but stimulated these processes. Moreover, TPA was found to induce additional changes in SV40-transformed keratinocytes. In particular it provoked the individualization of cells within the colonies. This effect was seen as little as 1 h after treatment and was reversible. This cellular alteration was accompanied by the reorganization of actin and by a decrease in the number of desmosomes; these changes were not observed after treatment of normal keratinocytes with TPA. These observations lead to the conclusion that TPA is able to trigger cellular responses which cannot be induced by SV40 products alone, but that TPA and some SV40 products can cooperate to elicit new responses, which could reflect a higher state of malignancy.
C
C
Delescluse
B A
BA
Bernard
J
J
Bailly
Y M
YM
Darmon
D000199:Actins / Q000032:analysis; D002460:Cell Line; D002472:Cell Transformation, Viral / Q000187:drug effects; D003599:Cytoskeleton / Q000187:drug effects / Q000648:ultrastructure; D003896:Desmosomes / Q000187:drug effects; D005353:Fibronectins / Q000096:biosynthesis; D005455:Fluorescent Antibody Technique; D006801:Humans; D007633:Keratins; D010704:Phorbols / Q000494:pharmacology*; D013539:Simian virus 40; D012867:Skin / Q000166:cytology* / Q000187:drug effects; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D000199:Actins; D005353:Fibronectins; D010704:Phorbols; D007633:Keratins; D013755:Tetradecanoylphorbol Acetate